Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Switching ART in the Context of Pregnancy

Listen to Roger Bedimo, MD, MS, FACP, discuss key considerations for switching ART in virologically suppressed patients who are pregnant or trying to conceive.
Roger Bedimo, MD, MS, FACP
Released: October 3, 2022

In this episode, Roger Bedimo, MD, MS, FACP, discusses key considerations for switching ART in virologically suppressed patients who are pregnant or trying to conceive. His discussion includes:

  • DHHS Perinatal Guideline recommendations
  • French Perinatal Cohort study on the implications of viral suppression when changing ART in the first trimester of pregnancy
  • IMPAACT 2010 Update on the safety and efficacy of DTG vs EFV and TDF vs TAF in pregnancy
  • DolPHIN-2 study of virological suppression with DTG- vs EFV-based ART started in late pregnancy

Information on this Educational Activity

Faculty

Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Roger Bedimo, MD, MS, FACP: consultant/advisor/speaker: Gilead Sciences, Janssen, Merck, Theratechnologies, ViiV.

Program Medium

This program has been made available online.

Acknowledgements

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings